Sanofi (SAN) News Today €91.28 -0.22 (-0.24%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSustainability All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sanofi and Teva’s duvakitug meets primary endpoints in Phase IIb trialDecember 18, 2024 | msn.comPromising Potential: Sanofi’s Strong Pipeline and Strategic Market Focus Drive Buy RatingDecember 18, 2024 | markets.businessinsider.comTeva, Sanofi Say IBD Treatment Achieved Higher Remission at TrialDecember 17, 2024 | marketwatch.comTeva Catapults 20%, Nearing A Five-Year High, After Scoring A Win With Sanofi-Tied DrugDecember 17, 2024 | yahoo.comAHF Thanks HRSA for Standing Up Against Drug Industry Attack on 340BDecember 17, 2024 | businesswire.comGilead Sciences Names Sanofi's Berger as Next Chief Medical OfficerDecember 12, 2024 | marketwatch.comSanofi CEO: "AI is a huge opportunity and we can't be deniers"December 11, 2024 | msn.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and NovoCure (NVCR)December 10, 2024 | markets.businessinsider.comSanofi’s Phase III trial of rilzabrutinib for thrombocytopenia meets endpointDecember 9, 2024 | finance.yahoo.comSanofi-Aventis Announces Positive Results For Rilzabrutinib In Phase 3 ITP StudyDecember 9, 2024 | markets.businessinsider.comJordan Chiles Is On a Mission To Raise Awareness for Early Type 1 Diabetes ScreeningDecember 7, 2024 | msn.comIndapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma ProgramDecember 6, 2024 | finance.yahoo.comSanofi To Invest $1.05 Bln For New Insulin Production Base In ChinaDecember 5, 2024 | markets.businessinsider.comSanofi Unveils $1 Billion China Investment to Boost ProductionDecember 3, 2024 | msn.comSanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in ChinaDecember 3, 2024 | msn.comSanofi announces biggest China investment deal amid China-EU trade tensionsDecember 2, 2024 | msn.comSanofi to invest $1 billion in insulin production site in Beijing, local authority saysDecember 2, 2024 | msn.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Sanofi (OtherSNYNF)November 29, 2024 | markets.businessinsider.comSanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovateNovember 29, 2024 | msn.comSanofi CEO Paul Hudson takes inspiration from ‘Fight Club’ to get his team hooked on AINovember 28, 2024 | msn.comPharma giant Sanofi opens $595 million vaccine facility in Singapore to prepare for potential pandemicsNovember 28, 2024 | msn.comSanofi Boosts Preparedness With $600 Million Singapore PlantNovember 27, 2024 | bloomberg.comMNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement…November 25, 2024 | finance.yahoo.comSanofi Plans to Change Hospital Drug-Discount ProgramNovember 22, 2024 | msn.comHow Sanofi Created A Company-Wide AI StrategyNovember 19, 2024 | forbes.comFDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticariaNovember 16, 2024 | msn.comEMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myelomaNovember 16, 2024 | msn.comSanofi: Sarclisa Recommended for EU Approval by CHMP to Treat Transplant-Ineligible Newly Diagnosed Multiple MyelomaNovember 14, 2024 | marketwatch.comSanofi Partners With Beano & Breakthrough T1D UK to Raise Awareness of autoimmune Type 1 DiabetesNovember 14, 2024 | sg.finance.yahoo.comRegeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung DiseaseNovember 14, 2024 | benzinga.comNovavax sees weak Covid vaccine sales, convinced Sanofi can do betterNovember 13, 2024 | bizjournals.comFormation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug developmentNovember 12, 2024 | finance.yahoo.comSanofi treatment of acute myeloid leukemia granted orphan statusNovember 12, 2024 | markets.businessinsider.comCEO of pharma giant Sanofi says businesses should stop ‘AI washing’November 12, 2024 | msn.comThe Accumulus Platform Powers Sanofi’s Submissions to Multiple Regulators Around the WorldNovember 8, 2024 | markets.businessinsider.comSandboxAQ Selected by Sanofi for Quantitative AI-Driven Biomarker IdentificationOctober 30, 2024 | tmcnet.comSanofi Launches Beyfortus Immunization Against RSV For Infants In Canada This FallOctober 28, 2024 | markets.businessinsider.comSanofi Positioned for Growth: Analyst David Risinger Recommends Buy Amid Strong Earnings OutlookOctober 28, 2024 | markets.businessinsider.comAnalysts Are Neutral on Top Healthcare Stocks: Sanofi (SNYNF), Siegfried Holding AG (SGFEF)October 27, 2024 | markets.businessinsider.comSanofi Profit, Sales Beat EstimatesOctober 25, 2024 | msn.comSanofi Profit Growth Beats Market View on Early Start of Vaccine SalesOctober 25, 2024 | money.usnews.comSanofi Expected to Report Higher Sales; Capital Allocation in Focus -- Earnings PreviewOctober 24, 2024 | marketwatch.comHow Sanofi Was Caught in The Middle of a €16 Billion Public BrawlOctober 24, 2024 | finance.yahoo.comCD&R Faces Tough Road to 20% Returns With SanofiOctober 23, 2024 | bloomberg.comSanofi Deal Jitters Imperil Stock’s Big ReboundOctober 22, 2024 | msn.comSanofi deal offers only partial headache reliefOctober 21, 2024 | ft.comSanofi confirms €16 billion sale of painkiller Doliprane to US investorsOctober 21, 2024 | yahoo.comSanofi’s $17bn sale of Opella to US investors advances following government dealOctober 21, 2024 | finance.yahoo.comFrench state takes stake in Sanofi unit to smooth €15.5bn US dealOctober 21, 2024 | ft.comPress Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareOctober 21, 2024 | uk.finance.yahoo.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. SAN Media Mentions By Week SAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAN News Sentiment▼0.140.60▲Average Medical News Sentiment SAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAN Articles This Week▼55▲SAN Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Compagnie Générale des Établissements Michelin Société en commandite par actions News Today Deutsche Bank Aktiengesellschaft News Today Bayer Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Genfit News Today Sartorius Stedim Biotech News Today Siemens Healthineers News Today Merck KGaA News Today Fresenius Medical Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:SAN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
